⌘K

Login Start Free

Home/Filings/4/0001611517-16-000003

4//SEC Filing

Immune Therapeutics, Inc. 4

Accession 0001611517-16-000003

CIK 0001559356operating

View on SEC.gov Company Profile

Filed

Jul 25, 8:00 PM ET

Accepted

Jul 26, 1:35 PM ET

Size

4.8 KB

Accession

0001611517-16-000003

Insider Transaction Report

Form 4

Period: 2016-07-18

Immune Therapeutics, Inc.IMUN

DirectorCHIEF EXECUTIVE OFFICER

Transactions

Purchase
Common Stock
2016-07-18+3,000,000→ 7,317,710 total

Footnotes (1)

[F1]Pursuant to Board Resolution in consideration of service to Company.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Immune Therapeutics, Inc.

CIK 0001559356

Entity typeoperating

IncorporatedFL

Related Parties

1

filerCIK 0001559356

Filing Metadata

Form type: 4
Filed: Jul 25, 8:00 PM ET
Accepted: Jul 26, 1:35 PM ET
Size: 4.8 KB

View on SEC.gov